Role of Th1 Immune Responses in the Pathogenesis of Hypertensive Kidney Injury
Role of Th1 Immune Responses in the Pathogenesis of Hypertensive Kidney Injury
批准号:
7866231
负责人:
Steven D Crowley
金额:
$38.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2015-07-31
关键词:
AddressAffectAngiotensin IIAnimalsAntibody FormationAntigen-Presenting CellsAttenuatedBlood PressureBone MarrowCD4 Positive T LymphocytesCD8B1 geneCell LineageCellsCharacteristicsChronicChronic Kidney FailureClinical TrialsComplement Factor DComplexCritical PathwaysCytokine Network PathwayDevelopmentGenerationsGeneticGenetic ProgrammingHelper-Inducer T-LymphocyteHypertensionImmuneImmune responseImmune systemImmunosuppressive AgentsIndividualInfiltrationInflammation MediatorsInflammatoryInfusion proceduresInjuryInjury to KidneyInterferon Type IIInterferonsKidneyKidney DiseasesLaboratoriesLeadMacrophage ActivationMediatingModelingModificationMusNatureOrganPathogenesisPathway interactionsPatternPhenotypePlayProductionProteinuriaReceptor, Angiotensin, Type 1Relative (related person)Renin-Angiotensin SystemRoleSourceT cell responseT-LymphocyteT-Lymphocyte SubsetsTNF geneTechniquesTestingTh1 CellsTh2 CellsTissuesTransplantationTumor Necrosis Factor-alphaTumor Necrosis FactorsWild Type Mousecytokinecytotoxicdesigninhibitor/antagonistmacrophagepreventpublic health relevancereceptorresearch studyresponsetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The renin-angiotensin system (RAS) plays a key role in the pathogenesis of chronic kidney injury. Clinical trials with RAS inhibitors suggest angiotensin II (Ang II) may promote renal injury through blood pressure- independent effects. Activation of the immune system by the RAS has been suggested as one mechanism mediating these actions. We have found that chronic infusion of Ang II causes significant kidney injury, infiltration of CD4+ T helper lymphocytes into the kidney, and enhanced expression of pro-inflammatory cytokines including interferon-g (IFN-g) and tumor necrosis factor-a (TNF-a). Administration of the broadly acting immunosuppressive agent mycyophenolate mofetil (MMF) abrogated these effects without affecting blood pressure. Accordingly, we hypothesize that activation of a CD4+ T cell-dependent cellular immune response by Ang II contributes to chronic kidney damage in this setting. Typically, CD4+ T cells do not directly mediate cytotoxic tissue injury. Rather, they regulate immune responses by differentiating into type 1 (Th1) or type 2 (Th2) CD4+ T helper cells. Whereas Th2 cells regulate antibody responses, Th1 cells secrete IFN-g leading to activation of macrophages and cytotoxic CD8+ T cells to mediate cellular damage. Activated macrophages in turn produce TNF-a, which further stimulates Th1 cells. We therefore suggest that Ang II acting through type I angiotensin (AT1) receptors promotes the development of a Th1 immune response in the kidney, with enhanced production of IFN-g and TNF-a leading directly to progressive kidney disease through blood pressure-independent mechanisms. To test this, we will examine Ang II-induced kidney injury in mouse lines with genetic modifications impacting: transcription factors critical for Th1 differentiation, key Th1 cytokines, and AT1 receptor responses in key cell lineages. In addition to CD4+ T cells, IFN-g and TNF-a are expressed by several immune cell lineages and even by renal parenchymal cells. Therefore, we have designed experiments to identify the cellular sources of these cytokines in Ang II- dependent kidney injury. Understanding how Th1 immune responses influence Ang II-induced renal damage should lead to more effective strategies for preventing progressive chronic kidney disease.
PUBLIC HEALTH RELEVANCE: Hypertension is a common cause of chronic kidney disease. This proposal explores how activation of a subset of T lymphocytes (Th1 cells) leads to kidney injury in angiotensin II-dependent hypertension. Understanding how Th1 immune responses influence angiotensin II-induced renal damage should lead to more effective strategies for preventing progressive chronic kidney disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The interleukin-1 receptor regulates crosstalk between myeloid and renal tubular cells in hypertension
-
批准号:10361423
-
项目类别:
-
资助金额:$43.28万
-
财政年份:2019
-
负责人:Steven D Crowley
-
依托单位:
Role of the M1 macrophage response in the progression of chronic kidney disease
-
批准号:8244168
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Steven D Crowley
-
依托单位:
Role of M1 Cytokines in the Progression of Chronic Kidney Disease
-
批准号:10347185
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Steven D Crowley
-
依托单位:
Role of the M1 macrophage response in the progression of chronic kidney disease
-
批准号:8413388
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Steven D Crowley
-
依托单位:
Role of the M1 macrophage response in the progression of chronic kidney disease
-
批准号:8597999
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Steven D Crowley
-
依托单位:
Role of M1 Cytokines in the Progression of Chronic Kidney Disease
-
批准号:10554255
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Steven D Crowley
-
依托单位:
Role of Th1 Immune Responses in the Pathogenesis of Hypertensive Kidney Injury
-
批准号:9253386
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2010
-
负责人:Steven D Crowley
-
依托单位:
Role of Th1 Immune Responses in the Pathogenesis of Hypertensive Kidney Injury
-
批准号:8515393
-
项目类别:
-
资助金额:$31.12万
-
财政年份:2010
-
负责人:Steven D Crowley
-
依托单位:
Role of Th1 Immune Responses in the Pathogenesis of Hypertensive Kidney Injury
-
批准号:8320389
-
项目类别:
-
资助金额:$32.25万
-
财政年份:2010
-
负责人:Steven D Crowley
-
依托单位:
Role of Th1 Immune Responses in the Pathogenesis of Hypertensive Kidney Injury
-
批准号:8081778
-
项目类别:
-
资助金额:$32.25万
-
财政年份:2010
-
负责人:Steven D Crowley
-
依托单位:
Role of Th1 Immune Responses in the Pathogenesis of Hypertensive Kidney Injury
-
批准号:8707438
-
项目类别:
-
资助金额:$32.25万
-
财政年份:2010
-
负责人:Steven D Crowley
-
依托单位:
Duke Training Grant in Nephrology
-
批准号:10208860
-
项目类别:
-
资助金额:$21.53万
-
财政年份:1995
-
负责人:Steven D Crowley
-
依托单位:
海外基金